Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 26 04:00PM ET
56.16
Dollar change
-0.01
Percentage change
-0.01
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y- Shs Outstand Perf Week1.73%
SponsorJPMorgan Chase ETF Type Tagsequity Return% 3Y- Total Holdings66 Perf Month-3.94%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM7.01M Perf Quarter3.13%
Index- Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagspharmaceutical Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M-16.49% 52W Range48.43 - 58.55 Perf YTD4.23%
Dividend TTM0.08 (0.14%) ESG Type Tags- Flows% 3M-37.81% 52W High-4.08% Beta-
Dividend Ex-DateDec 19, 2023 Dividend Type Sector/Theme Flows% YTD-37.81% 52W Low15.95% ATR (14)0.32
Expense0.65% Structure Type Region Flows% 1Y RSI (14)46.33 Volatility0.03% 0.06%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.19 Prev Close56.16
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.59K Price56.16
SMA20-0.48% SMA50-1.68% SMA2002.78% Trades Volume114 Change-0.01%
Jpmorgan Healthcare Leaders ETF seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.